Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 7/2003

Content (9 Articles)

Editorial

Editorial statement from Graham Pawelec

Graham Pawelec

Original Article

Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses

Yaling Zhou, Julie A. McEarchern, Edward Howard, Gary Pestano, Michael L. Salgaller, Marnix L. Bosch

Original Article

Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells

Axel C. P. Diederichsen, J. v. B. Hjelmborg, Per B. Christensen, Jesper Zeuthen, Claus Fenger

Original Article

Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism

Linda M. Thurmond, Julie B. Stimmel, Adrienne C. Ingram, Christian H. Ryan, Doris M. Murray, Derek J. Eberwein, Sam M. Witherspoon, Vincent C. Knick

Original Article

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects

Thierry Lesimple, Annick Moisan, André Carsin, Isabelle Ollivier, Mireille Mousseau, Bernard Meunier, Claudine Leberre, Brigitte Collet, Véronique Quillien, Bernard Drenou, Claudia Lefeuvre-Plesse, Jacqueline Chevrant-Breton, Louis Toujas

Original Article

Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation

Radek Spisek, Gwenola Bougras, Frederic Ebstein, Delphine Masse, Khaled Meflah, Dorian McIlroy, Marc Gregoire

Original Article

Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation

Ilse Houtenbos, Theresia M. Westers, Anita G. M. Stam, Tanja D. de Gruijl, Rik J. Scheper, Gert J. Ossenkoppele, Arjan A. van de Loosdrecht

Original Article

Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells

Peter Ujhazy, Gintaras Zaleskis, Enrico Mihich, M. Jane Ehrke, Erica S. Berleth

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine